Skip to main content
. 2022 Mar 9;23(6):2944. doi: 10.3390/ijms23062944

Figure 5.

Figure 5

Clot strength is directly proportional to the concentration of fibrinogen supplementation. Thromboelastography was performed on whole blood (WB) or 40% hemodiluted clots (HD) ± (A) RiaSTAP®, (B) cryoprecipitate or (C) FibCLOT® (0.5–2 mg/mL) using EXTEM reagent and analyzed using ROTEM thromboelastography. Data represent mean data ± SEM of maximum clot firmness (MCF). (D) Correlation of MCF with fibrinogen concentration. n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001 vs. 0.5 mg/mL.